Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01688076 · ClinicalTrials.gov registry record · Phase 4
Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection
A Phase 4 study of Forehead Rhytid Complex and Glabellar Rhytid Complex, sponsored by Northwestern University.
- Active
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01688076 is a Phase 4 study of Forehead Rhytid Complex and Glabellar Rhytid Complex that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01688076, a Phase 4 study of Forehead Rhytid Complex and Glabellar Rhytid Complex, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This cross-over design study will evaluate the onset of action, efficacy, and duration of botulinum toxin A treatment on forehead/glabellar rhytid complexes with and without subsequent muscle contraction.
Conditions Studied
Interventions
- PROCEDURE Botulinum Toxin A
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine, Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-01 |
| Est. Completion | 2025-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01688076
The ClinicalTrials.gov registry entry for NCT01688076 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Forehead Rhytid Complex appearing as the primary indexed condition, and to 1 intervention - of which Botulinum Toxin A is the first listed.
NCT01688076 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01688076 about?
NCT01688076 is a clinical study titled "Treatment of Forehead/Glabellar Rhytide Complex With Botulinum Toxin A Injection". This cross-over design study will evaluate the onset of action, efficacy, and duration of botulinum toxin A treatment on forehead/glabellar rhytid complexes with and without subsequent muscle contraction.
What is the current status of trial NCT01688076?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2012-01. Estimated completion is 2025-12.
What conditions does trial NCT01688076 study?
This clinical trial studies the following conditions: Forehead Rhytid Complex, Glabellar Rhytid Complex.
What interventions are being tested in trial NCT01688076?
The interventions under investigation include: Botulinum Toxin A (PROCEDURE).
Who is sponsoring clinical trial NCT01688076?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01688076 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.